October 18, 2001 Corixa Corporation 1124 Columbia Street Suite 200 Seattle, Washington 98104, U.S.A. Attention: Chairman RE: Collaboration Agreement Dated October 23, 1998 between Coulter Pharmaceutical, Inc. and SmithKline Beecham Corporation Dear...Letter Agreement • March 1st, 2002 • Corixa Corp • Biological products, (no disgnostic substances)
EXHIBIT 10.10 SECOND AMENDMENT TO LEASE 1102 COLUMBIA STREET, SEATTLE, WASHINGTON THIS SECOND AMENDMENT TO LEASE 1102 COLUMBIA STREET, SEATTLE, WASHINGTON ("Amendment"), dated and effective as of June 30, 1997, is entered into by and between CORIXA...Corixa Corp • March 1st, 2002 • Biological products, (no disgnostic substances) • Washington
AS TENANTLease Agreement • March 1st, 2002 • Corixa Corp • Biological products, (no disgnostic substances) • California
RECITALSLease Agreement • March 1st, 2002 • Corixa Corp • Biological products, (no disgnostic substances)
February 12, 2001 Corixa Corporation 1124 Columbia Street Suite 200 Seattle, Washington 98104, U.S.A. Attention: Chairman RE: Collaboration Agreement Dated October 23, 1998 between Coulter Pharmaceutical, Inc. and SmithKline Beecham Corporation Dear...Collaboration Agreement • March 1st, 2002 • Corixa Corp • Biological products, (no disgnostic substances)
EXHIBIT 10.66 FIRST AMENDMENT TO REGISTRATION RIGHTS AGREEMENT This First Amendment to Registration Rights Agreement (this "Amendment"), is entered into as of February 28, 2002, between Corixa Corporation, a Delaware corporation (the "Company"), and...Registration Rights Agreement • March 1st, 2002 • Corixa Corp • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.60 LOAN AGREEMENT CORIXA CORPORATIONLoan Agreement • March 1st, 2002 • Corixa Corp • Biological products, (no disgnostic substances)
April 20, 2000 Coulter Pharmaceutical, Inc 600 Gateway Boulevard South San Francisco, California 94080-7014, U.S.A. Attention: Chief Financial Officer RE: Collaboration Agreement Dated October 23, 1998 Between Coulter Pharmaceutical, Inc. and...Collaboration Agreement • March 1st, 2002 • Corixa Corp • Biological products, (no disgnostic substances)
ANDDevelopment and License Agreement • March 1st, 2002 • Corixa Corp • Biological products, (no disgnostic substances) • Washington
September 28, 2001License and Collaborative Research Agreement • March 1st, 2002 • Corixa Corp • Biological products, (no disgnostic substances)
*CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
Exhibit 10.67 *CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED. VIA FACSIMILE AND...Letter Agreement Regarding Development and License Agreement • March 1st, 2002 • Corixa Corp • Biological products, (no disgnostic substances) • Washington
EXHIBIT 10.11 THIRD AMENDMENT TO LEASE 1102 COLUMBIA STREET, SEATTLE, WASHINGTON THIS THIRD AMENDMENT TO LEASE 1102 COLUMBIA STREET, SEATTLE, WASHINGTON ("Third Amendment"), dated as of November 1, 1998, is entered into by and between CORIXA...Corixa Corp • March 1st, 2002 • Biological products, (no disgnostic substances) • Washington
RECITALSCorixa Corp • March 1st, 2002 • Biological products, (no disgnostic substances)
EXHIBIT 10.65 FIRST AMENDMENT TO PRIVATE EQUITY LINE FINANCING AGREEMENT This First Amendment to Private Equity Line Financing Agreement (this "Amendment"), is entered into as of February 28, 2002, between Corixa Corporation, a Delaware corporation...Private Equity Line Financing Agreement • March 1st, 2002 • Corixa Corp • Biological products, (no disgnostic substances) • New York
